Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials-Reference-Cited by-同舟云学术

Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials

Published:2020-08 Issue:8 Volume:8 Page:672-682
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Black Dennis M,Bauer Douglas C,Vittinghoff Eric,Lui Li-Yung,Grauer Andreas,Marin Fernando,Khosla Sundeep,de Papp Anne,Mitlak Bruce,Cauley Jane A,McCulloch Charles E,Eastell Richard,Bouxsein Mary L

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference64 articles.

1. Treatment of low bone density or osteoporosis to prevent fractures in men and women: a clinical practice guideline update from the American College of Physicians;Qaseem;Ann Intern Med,2017

2. Change in bone density and reduction in fracture risk: a meta-regression of published trials;Bouxsein;J Bone Miner Res,2019

3. Time to review the role of surrogate end points in health policy: state of the art and the way forward;Ciani;Value Health,2017

4. Biomarker qualification: toward a multiple stakeholder framework for biomarker development, regulatory acceptance, and utilization;Amur;Clin Pharmacol Ther,2015

5. Use of surrogate end points in healthcare policy: a proposal for adoption of a validation framework;Ciani;Nat Rev Drug Discov,2016

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nail–Plate Constructs for Treating Distal Femur Fractures: A Systematic Review of Biomechanical Studies;Surgeries;2024-09-06

2. Olink Proteomics for the Identification of Biomarkers for Early Diagnosis of Postmenopausal Osteoporosis;Journal of Proteome Research;2024-09-03

3. Treatment effects, adverse outcomes and cardiovascular safety of romosozumab – Existing worldwide data: A systematic review and meta-analysis;Journal of Orthopaedic Translation;2024-09

4. The Association of Systemic and Mandibular Bone Mineral Density in Postmenopausal Females with Osteoporosis;Medicina;2024-08-14

5. The relationship between treatment-related changes in total hip BMD measured after 12, 18, and 24 mo and fracture risk reduction in osteoporosis clinical trials: the FNIH-ASBMR-SABRE project;Journal of Bone and Mineral Research;2024-08-04